tiprankstipranks
InnoCan Pharma (TSE:INNO)
:INNO
Canadian Market
INNO
InnoCan Pharma
RESEARCH TOOLSreports

InnoCan Pharma (INNO) Income Statement

22 Followers

InnoCan Pharma Income Statement

Last quarter (Q4 2025), InnoCan Pharma's total revenue was $4.99M, a decrease of -36.02% from the same quarter last year. In Q4, InnoCan Pharma's net income was $2.00M. See InnoCan Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Mar 24Dec 22Mar 22
Total Revenue
$ 26.61M$ 29.44M$ 13.66M$ 2.56M$ 196.00K
Gross Profit
$ 23.93M$ 26.19M$ 11.98M$ 2.11M$ 121.00K
Operating Expenses
$ 25.19M$ 27.43M$ 8.18M$ 8.37M$ 7.60M
Depreciation and Amortization
$ 42.00K$ 35.00K$ 33.00K$ 35.00K$ 43.00K
EBITDA
$ 130.00K$ 961.00K$ -3.77M$ -3.85M$ -10.04M
Operating Income
$ -1.25M$ -1.25M$ 3.80M$ -6.27M$ -7.48M
Other Income/Expenses
$ 1.34M$ 2.17M$ -7.84M$ 2.38M$ -2.61M
Pretax Income
$ 85.00K$ 919.00K$ -4.03M$ -3.89M$ -10.09M
Net Income
$ -1.12M$ -1.83M$ -4.70M$ -3.89M$ -10.06M
Per Share Metrics
Basic EPS
$ -0.25$ -0.42$ -1.19$ -1.01$ -2.91
Diluted EPS
$ -0.25$ -0.42$ -1.19$ -1.01$ -2.91
Weighted Average Shares Outstanding
 4.48M 4.20M---
Weighted Average Shares Outstanding (Diluted)
 4.48M 4.20M---
Currency in USD

InnoCan Pharma Earnings and Revenue History